Agoracom: Small Cap Investment - Zenith Epigenetics

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

masila

Rank: Vice President [?]

Points: 818 [?]

Votes: 16 Score: 3.7 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Equity offering

posted on Jun 04, 2018 04:39PM

Wasn't sure if the offering was going to be for ZCC or ZEL. If ZCC, does that mean that new shareholders would be entitled to the royalty stream from RVX?

masila

5 Recommendations

Re: Equity offering

Hartland

Jun 04, 2018 04:51PM

Re: Equity offering

fouremm

Jun 04, 2018 05:21PM

Re: Equity offering

tada

Jun 04, 2018 07:05PM

Re: Equity offering